Cellectis (CLLS) Operating Expenses (2015 - 2026)

Cellectis' Operating Expenses history runs 12 years deep, the most recent figure standing at -$32.7 million for Q1 2026.

• In Q1 2026, Operating Expenses fell 24.83% year-over-year to -$32.7 million; the TTM figure through Mar 2026 stood at -$119.2 million (down 10165.46% YoY), while the FY2025 annual figure was -$112.7 million, changed N/A from the prior year.
• Operating Expenses for Q1 2026 stood at -$32.7 million, down from -$29.6 million in the prior quarter.
• The five-year high for Operating Expenses was $85.9 million in Q4 2023, with the low at -$33.0 million in Q1 2022.
• The 5-year median for Operating Expenses is -$27.4 million (2024), against an average of -$14.7 million.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses jumped 473.64% in 2023, then tumbled 135.64% in 2025.
• Cellectis' Operating Expenses stood at -$23.0 million in 2022, then surged by 473.64% to $85.9 million in 2023, then decreased by 3.43% to $82.9 million in 2024, then sank by 135.64% to -$29.6 million in 2025, then fell by 10.68% to -$32.7 million in 2026.
• Business Quant data shows CLLS's Operating Expenses at -$32.7 million in Q1 2026, -$29.6 million in Q4 2025, and -$29.1 million in Q3 2025.